Let's Chat About ... Gene Therapy for Leber congenital amaurosis
Join us as we chat with Dr. Michel Michaelides, a founding member of MeiraGTx and Professor of Ophthalmology. MeiraGTX saw statistically significant improvement demonstrated in vision-guided mobility and visual function in treated eyes compared to untreated eyes during its Phase 1/2 clinical trial of AAV-RPE65 in both adult and pediatric patients with RPE65-deficiency.
▶︎
X Linked Retinoschisis with Professor Andrew Lotery
▶︎
Living with LCA: The Day Family
▶︎
Blindness to Sight: Hannah R.'s Story
▶︎
Let's Chat About ... what's in the pipeline for inherited retinal disease treatments.
▶︎
Quantum Consciousness and the Origin of Life
▶︎
My Experience with Leber's Congenital Amaurosis (LCA) | RDH12 Gene Mutation
▶︎
Leber Congenital Amaurosis
▶︎
But what is quantum computing? (Grover's Algorithm)
▶︎
Boy Hopeful Groundbreaking Gene Therapy Will Improve Vision
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Doctor on How Screen Time Hurts Kids' Cognitive Development
▶︎
Leber congenital amaurosis: Can CRISPR cure genetic blindness?
▶︎
Clara Mattei: capitalism is not natural - it’s enforced
▶︎
No.1 Brain Scientist: Your Brain Is Lying To You! Here's How I Discovered The Truth!
▶︎
Retinitis Pigmentosa | Genetics, Pathophysiology, Signs & Symptoms, Diagnosis, Treatment
▶︎
The Loud Absence: Where is God in Suffering? | John Lennox at Harvard Medical School
▶︎
Bioelectricity, Morphogenesis, and Two-Headed Worms | Michael Levin
▶︎
Nervous System Regulation (999 Hz) | 1 hour handpan music | Malte Marten
▶︎
Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe
▶︎